Earnings Call · Q2 FY2023·2023-08-12

Q2 23EPS +28.57%·Rev n/aQ1 23EPS -15.52%·Rev n/aQ4 22EPS +100.00%*·Rev n/aQ3 22EPS +15.43%·Rev n/a⚠ consensus missing

ABEONA THERAPEUTICS INC. ABEO

Greg Gin — Vice President of Investor Relations and Corporate Communications

Vish Seshadri — Chief Executive Officer

Joe Vazzano — Chief Financial Officer

0.0%1d on move date+0.4% vs SPY3d+0.3%5d+4.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABEO calls or request research access.

More ABEO calls Browse calls Request research access